报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
---|---|---|---|---|---|---|---|---|
2024-09-30 | 48.31% | 15.26% | -0.71% | 80/129 | 53.43% | 佰仁医疗 | 88.56% | 行业排名> |
2024-06-30 | 48.65% | 18.65% | 8.52% | 78/129 | 53.65% | 佰仁医疗 | 89.27% | 行业排名> |
2024-03-31 | 44.83% | 4.49% | -10.93% | 81/129 | 53.62% | 佰仁医疗 | 89.28% | 行业排名> |
2023-12-31 | 50.33% | -5.85% | 20.09% | 76/129 | 53.85% | 正海生物 | 89.9% | 行业排名> |
2023-09-30 | 41.91% | -28.79% | 2.21% | 89/129 | 54.06% | 正海生物 | 90.39% | 行业排名> |
2023-06-30 | 41% | -30.95% | -4.44% | 89/129 | 53.61% | 正海生物 | 90.3% | 行业排名> |
2023-03-31 | 42.91% | -29.4% | -19.74% | 86/129 | 53.66% | 正海生物 | 89.78% | 行业排名> |
2022-12-31 | 53.46% | -13.54% | -9.16% | 69/129 | 54.04% | 三友医疗 | 90.18% | 行业排名> |
2022-09-30 | 58.85% | -5.79% | -0.89% | 58/129 | 55.13% | 三友医疗 | 90.14% | 行业排名> |
2022-06-30 | 59.38% | -6.65% | -2.29% | 60/129 | 54.78% | 三友医疗 | 90.29% | 行业排名> |
2022-03-31 | 60.78% | 2% | -1.71% | 55/129 | 56.28% | 三友医疗 | 90.73% | 行业排名> |
2021-12-31 | 61.83% | -14.76% | -1.02% | 58/129 | 57.38% | 三友医疗 | 90.5% | 行业排名> |
2021-09-30 | 62.47% | 2% | -1.8% | 52/129 | 59.17% | 三友医疗 | 90.29% | 行业排名> |
2021-06-30 | 63.61% | -22.33% | -12.3% | 54/129 | 58.42% | 正海生物 | 90.78% | 行业排名> |
2020-12-31 | 72.53% | 69.58% | -11.43% | 36/129 | 59.67% | 正海生物 | 91.59% | 行业排名> |
2020-06-30 | 81.9% | 2% | 91.48% | 14/129 | 59.94% | 正海生物 | 92.23% | 行业排名> |
2019-12-31 | 42.77% | 11.23% | 11.23% | 87/129 | 56.37% | 正海生物 | 92.69% | 行业排名> |
2018-12-31 | 38.45% | 0.21% | 0.21% | 82/129 | 55.53% | 正海生物 | 92.61% | 行业排名> |
2017-12-31 | 38.37% | 2% | 2% | 76/129 | 55.34% | 正海生物 | 94.38% | 行业排名> |